help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KLEINSASSER, A.
Right arrow Articles by LINDNER, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KLEINSASSER, A.
Right arrow Articles by LINDNER, K. H.

Am. J. Respir. Crit. Care Med., Volume 163, Number 2, February 2001, 339-343

Sildenafil Modulates Hemodynamics and Pulmonary Gas Exchange

AXEL KLEINSASSER, ALEXANDER LOECKINGER, CHRISTOPH HOERMANN, FRIEDRICH PUEHRINGER, NORBERT MUTZ, GEORG BARTSCH, and KARL H. LINDNER

Department of Anesthesiology and Critical Care Medicine and Department of Urology, Leopold-Franzens-University of Innsbruck, Innsbruck, Austria

The effects of sildenafil (Viagra) on hemodynamics and pulmonary gas exchange remain uncertain. The aim of this study was to investigate what effect sildenafil had on gas exchange. A total of 24 anesthetized pigs were randomly assigned into four groups of six animals each: Group Low received 25 mg of sildenafil, which is equivalent to half the recommended dose for humans; group Normal received 50 mg; group High received 100 mg; and one group served as control. Inert gas and hemodynamic measurements were performed to define dose-dependent effects of sildenafil on cardiac and pulmonary function. Measurements were taken 30, 60, and 90 min after the administration of sildenafil via gastric tube. All doses of sildenafil caused significant increases in intrapulmonary shunt flow (maximum amplitude, 4.4 ± 0.3 to 11.9 ± 0.5%; mean ± SEM), which was reflected by marked decreases in PaO2. Sildenafil elicited some significant increases in cardiac index (CI) (high dose, 142 ± 10 to 196 ± 13 ml kg-1, mean ± SEM). Mean arterial pressure was significantly depressed after the high dose of sildenafil. Pulmonary artery pressure was decreased after high-dose sildenafil (maximum amplitude, 16 ± 1.6 to 14 ± 1.8, mean ± SEM). No significant differences between the three treatment groups were found. Sildenafil represents and orally active substance with phosphodiesterase V inhibitory and cardiac output-increasing actions. PaO2 decrease after 50 and 100 mg of sildenafil was observed in the presence of significant rises in pulmonary shunt flow and CI.




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M. D. Guazzi
Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure
J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2136 - 2144.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. D. Lewis, R. Shah, K. Shahzad, J. M. Camuso, P. P. Pappagianopoulos, J. Hung, A. Tawakol, R. E. Gerszten, D. M. Systrom, K. D. Bloch, et al.
Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension
Circulation, October 2, 2007; 116(14): 1555 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Namachivayam, U. Theilen, W. W. Butt, S. M. Cooper, D. J. Penny, and L. S. Shekerdemian
Sildenafil Prevents Rebound Pulmonary Hypertension after Withdrawal of Nitric Oxide in Children
Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1042 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. Fesler, A. Pagnamenta, B. Rondelet, F. Kerbaul, and R. Naeije
Effects of sildenafil on hypoxic pulmonary vascular function in dogs
J Appl Physiol, October 1, 2006; 101(4): 1085 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. Roizenblatt, C. Guilleminault, D. Poyares, F. Cintra, A. Kauati, and S. Tufik
A Double-blind, Placebo-Controlled, Crossover Study of Sildenafil in Obstructive Sleep Apnea.
Arch Intern Med, September 18, 2006; 166(16): 1763 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Guazzi, G. Tumminello, F. Di Marco, C. Fiorentini, and M. D. Guazzi
The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2339 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. G. Raja and S. H. Nayak
Sildenafil: Emerging Cardiovascular Indications
Ann. Thorac. Surg., October 1, 2004; 78(4): 1496 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin
Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest, July 1, 2004; 126(1_suppl): 35S - 62S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. H. Leuchte, M. Schwaiblmair, R. A. Baumgartner, C. F. Neurohr, T. Kolbe, and J. Behr
Hemodynamic Response to Sildenafil, Nitric Oxide, and Iloprost in Primary Pulmonary Hypertension
Chest, February 1, 2004; 125(2): 580 - 586.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Itoh, N. Nagaya, T. Fujii, T. Iwase, N. Nakanishi, K. Hamada, K. Kangawa, and H. Kimura
A Combination of Oral Sildenafil and Beraprost Ameliorates Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 34 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. Hironaka, M. Hongo, A. Sakai, E. Mawatari, F. Terasawa, N. Okumura, A. Yamazaki, Y. Ushiyama, Y. Yazaki, and O. Kinoshita
Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats
Cardiovasc Res, December 1, 2003; 60(3): 692 - 699.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
I. Schulze-Neick, P. Hartenstein, J. Li, B. Stiller, N. Nagdyman, M. Hubler, G. Butrous, A. Petros, P. Lange, and A. N. Redington
Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease
Circulation, September 9, 2003; 108(90101): II-167 - 173.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Reffelmann and R. A. Kloner
Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease
Circulation, July 15, 2003; 108(2): 239 - 244.
[Full Text] [PDF]

Home page
 LupusHome page
J Molina, E Lucero, S Luluaga, V Bellomio, A Spindler, and A Berman
Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy
Lupus, April 1, 2003; 12(4): 321 - 323.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. M. Hoeper, N. Galie, G. Simonneau, and L. J. Rubin
New Treatments for Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1209 - 1216.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. S. Shekerdemian, H. B. Ravn, and D. J. Penny
Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1098 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. F. Lodato
Viagra for Impotence of Pulmonary Vasodilator Therapy?
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 312 - 313.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society